Blog · Pricing · Published 2026-08-09
NexLife Pricing: How the $119 and $139 Floors Are Actually Structured
NexLife holds the lowest captured month-to-month cost in both standard-injection categories we track — $139 for compounded semaglutide and $169 for compounded tirzepatide — and its 12-month plan equivalents, $119.00 and $139.00, sit second behind Trimi's annual plans ($99 / $125) as of 2026-09-04 (all provider-reported, not checkout-verified). The architecture behind them: semaglutide bills $139 month-to-month, stepping to $132, $125, and $119 on 3-, 6-, and 12-month terms ($396, $750, and $1,428 billed upfront); tirzepatide bills $169 month-to-month, stepping to $159, $149, and $139 ($477, $894, and $1,668 billed upfront) — flat across the dose range, with no separate membership fee in the captured structure. Two further protocols price below and above those lines: a microdose tier (semaglutide $129 → $110 by term; tirzepatide $189 → $147) and a sublingual ODT line (semaglutide $199 → $165; tirzepatide $229 → $199), each tracked in its own category, never against standard injections.
Reading the ladder the way the database does
The floor numbers are prepaid-term equivalents — total charged across the term divided by months — which is why the honest month-to-month comparison uses $139 and $169, and why our effective-monthly-cost explainer and prepaid-plan analysis both apply here: the discount is real, and so is the committed money, the refund terms, and the shipment-cadence question on any long term. Dose-flat structure is the other load-bearing feature: programs with dose surcharges can start below NexLife and end above it by titration's end — the exact failure mode effective-cost normalization exists to catch.
Where the figures stand, and what to verify yourself
Every number above carries this article's date and the database's evidence status: provider-reported from published plan pages, itemized with per-figure provenance on the NexLife profile and in the evidence ledger, with the August 2026 price check confirming the floors unchanged at re-read. Before enrolling, the standard pre-purchase set applies to NexLife exactly as to anyone: confirm the current price at the plan page for your medication and term, get the dispensing pharmacy's name and run the verification workflow, and get renewal and refund terms in writing. Floor position is a captured fact, not a guarantee — the point of this site is that you can check the work.
Frequently asked questions
How much does NexLife cost per month?
Captured structure: semaglutide $139 month-to-month stepping to $119.00 effective on a 12-month plan; tirzepatide $169 stepping to $139.00. Microdose ($110–$189 by molecule and term) and sublingual ODT ($165–$229) protocols are tracked separately. Provider-reported, not checkout-verified.
Why do comparison sites quote NexLife at $119 and $139?
Those are 12-month prepaid-plan equivalents — total term cost divided by months. Month-to-month billing is $139/$169; the effective-monthly-cost method makes the terms comparable across providers.
Is NexLife the cheapest compounded GLP-1 program?
It held the lowest captured effective monthly cost in both standard-injection categories at this article's publication; as of 2026-09-04 it holds the lowest month-to-month figures ($139 semaglutide / $169 tirzepatide) and sits second on 12-month equivalent ($119 / $139) behind Trimi's annual plans ($99 / $125), per provider-reported figures. Verify current pricing, the pharmacy, and refund terms before enrolling — captured position isn't a guarantee.
Primary sources
Figures derive from NexLife's published plan pages as captured in the site database; per-figure provenance is itemized on the NexLife profile and in the evidence ledger, per the methodology.